Literature DB >> 15110223

Familial clustering of autoimmune diseases in patients with dilated cardiomyopathy.

Constantinos J Limas1, Panayotis Iakovis, Alexandros Anyfantakis, Christos Kroupis, Dennis V Cokkinos.   

Abstract

In this study, we examined the hypothesis that dilated cardiomyopathy (DCM) shares genetic risk factors with other diseases of presumed autoimmune etiology, and, therefore, the same multiple genes in combination with environmental factors lead to numerous different autoimmune diseases. In accordance with this hypothesis, we showed an increased prevalence of autoimmune diseases in first-degree relatives of patients with DCM. Also, T-cell activation, as reflected in high levels of the soluble interleukin-2 receptor, appears to identify patients with DCM with a clustering of autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15110223     DOI: 10.1016/j.amjcard.2004.01.060

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Transcriptomic biomarkers for the accurate diagnosis of myocarditis.

Authors:  Bettina Heidecker; Michelle M Kittleson; Edward K Kasper; Ilan S Wittstein; Hunter C Champion; Stuart D Russell; Ralph H Hruban; E Rene Rodriguez; Kenneth L Baughman; Joshua M Hare
Journal:  Circulation       Date:  2011-03-07       Impact factor: 29.690

Review 2.  Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy.

Authors:  Jason M Lappé; Clara M Pelfrey; W H Wilson Tang
Journal:  J Card Fail       Date:  2008-05-27       Impact factor: 5.712

Review 3.  Targeting anti-beta-1-adrenergic receptor antibodies for dilated cardiomyopathy.

Authors:  Priyesh A Patel; Adrian F Hernandez
Journal:  Eur J Heart Fail       Date:  2013-05-02       Impact factor: 15.534

4.  Antibodies to cardiac receptors.

Authors:  V Boivin-Jahns; A Schlipp; S Hartmann; P Panjwani; K Klingel; M J Lohse; G Ertl; R Jahns
Journal:  Herz       Date:  2012-12       Impact factor: 1.443

5.  Novel receptor-derived cyclopeptides to treat heart failure caused by anti-β1-adrenoceptor antibodies in a human-analogous rat model.

Authors:  Valérie Boivin; Niklas Beyersdorf; Dieter Palm; Viacheslav O Nikolaev; Angela Schlipp; Justus Müller; Doris Schmidt; Vladimir Kocoski; Thomas Kerkau; Thomas Hünig; Georg Ertl; Martin J Lohse; Roland Jahns
Journal:  PLoS One       Date:  2015-02-20       Impact factor: 3.240

Review 6.  Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management.

Authors:  Alida L P Caforio; Renzo Marcolongo; Roland Jahns; Michael Fu; Stephan B Felix; S Iliceto
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.654

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.